| 1. |
Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
Nature. 1993;364(6432):33–9.
|
| |
| 2. |
Stern LJ, Brown JH, Jardetzky TS, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza
virus peptide. Nature. 1994;368(6468):215–21.
|
| |
| 3. |
Bhasin M, Singh H, Raghava GP. MHCBN: a comprehensive database of MHC binding and non-binding peptides. Bioinformatics. 2003;19(5):665–6.
|
| |
| 4. |
Brusic V, Rudy G, Harrison LC. MHCPEP, a database of MHC-binding peptides: update 1997. Nucleic Acids Res. 1998;26(1):368–71.
|
| |
| 5. |
McSparron H, Blythe MJ, Zygouri C, Doytchinova IA, Flower DR. JenPep: a novel computational information resource for immunobiology
and vaccinology. J Chem Inf Comput Sci. 2003;43(4):1276–87.
|
| |
| 6. |
Blythe MJ, Doytchinova IA, Flower DR. JenPep: a database of quantitative functional peptide data for immunology. Bioinformatics. 2002;18(3):434–9.
|
| |
| 7. |
NIAID. Biodefense Grants and Contracts: FY 2004 Awards http:// www2.niaid.nih.gov/biodefense/research/2004awards..
|
| |
| 8. |
Brusic V, Rudy G, Honeyman G, Hammer J, Harrison L. Prediction of MHC class II-binding peptides using an evolutionary algorithm
and artificial neural network. Bioinformatics. 1998;14(\refch25:eqn25.1):121–30.
|
| |
| 9. |
Kato R, Noguchi H, Honda H, Kobayashi T. Hidden Markov model-based approach as the first screening of binding peptides that
interact with MHC class II molecules. Enzyme Microb Technol. 2003;33(4):472–81.
|
| |
| 10. |
Bhasin M, Raghava GP. SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence. Bioinformatics. 2004;20(3):421–3.
|
| |
| 11. |
Afifi AA, Clark V. Computer-aided multivariate analysis. 2nd edn. New York: Van Nostrand Reinhold; 1990.
|
| |
| 12. |
Mallios WS. Statistical modeling: applications in contemporary issues. 1st edn. Ames: Iowa State University Press; 1989.
|
| |
| 13. |
Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240(4857): 1285–93.
|
| |
| 14. |
Mallios RR. A consensus strategy for combining HLA-DR binding algorithms. Hum Immunol. 2003;64(9):852–6.
|
| |
| 15. |
Chicz RM, Urban RG, Lane WS, et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related
molecules and are heterogeneous in size. Nature. 1992;358(6389):764–8.
|
| |
| 16. |
Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed
peptide motifs, constraints of processing, and general rules. Immunogenetics. 1994;39(4):230–42.
|
| |
| 17. |
Hammer J, Takacs B, Sinigaglia F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med. 1992;176(4):1007–13.
|
| |
| 18. |
Mallios WS. The analysis of sports forecasting: modeling parallels between sports gambling and financial markets. Boston: Kluwer Academic; 2000.
|
| |